Essilor Promotes FDA-Authorized Stellest Lenses as Study Shows 71% Slower Childhood Myopia Progression
Updated
Updated · health.yahoo.com · Aug 18
Essilor Promotes FDA-Authorized Stellest Lenses as Study Shows 71% Slower Childhood Myopia Progression
3 articles · Updated · health.yahoo.com · Aug 18
Summary
Essilor Stellest used a Paris press event to spotlight childhood myopia as a growing health risk and position its FDA-authorized glasses as a way to slow worsening vision in children.
One cited study found Stellest lenses slowed myopia progression by 71% over two years, while experts said earlier onset raises the risk of high myopia, glaucoma and retinal detachment later in life.
About 50% of the global population is projected to be myopic by 2050, with specialists linking the rise to more near work, less outdoor time and family history.
Doctors urged regular pediatric eye exams because children often do not report blurred distance vision, and recommended at least two hours outdoors daily plus 20-20-20 breaks from close-up work.
Families were also told to ask about other myopia-control options, including soft contact lenses, low-dose atropine drops and Ortho-K lenses, as concern grows over long-term childhood vision damage.